Polyrizon (PLRZ) shares fell in their Nasdaq trading debut on Tuesday after the development-stage biotech company priced its $4.2 million initial public offering.
The stock was down about 66% in recent trading after opening at $1.64.
Polyrizon priced its IPO of 958,903 units at a combined price of $4.38 per unit, with each unit each consisting of one share and three warrants to buy one share per warrant, with an initial exercise price of $4.38 per share.
Aegis Capital has a 45-day option to acquire up to 143,835 additional units. The offering is expected to close Wednesday.
Price: 1.47, Change: -2.91, Percent Change: -66.44
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。